The hippocampal dentate gyrus in aging and Alzheimer's disease: boosting transcription of retinoic acid-sensitive genes through vitamin A supplementation and HDAC inhibition

衰老和阿尔茨海默病中的海马齿状回:通过补充维生素 A 和抑制 HDAC 来促进视黄酸敏感基因的转录

基本信息

项目摘要

PROJECT SUMMARY / ABSTRACT The hippocampal dentate gyrus (DG), critically involved in learning and memory, is a vulnerable region in both age-related cognitive impairment (ARCD) and Alzheimer’s disease (AD). Causal upstream signaling mechanisms that lead to AD remain poorly understood. Across lifespan, excess reactive oxygen species (ROS) accumulate, causing oxidative damage to proteins, lipids, and DNA. This process is termed oxidative stress (OS). Dietary antioxidants (AOs) normally scavenge excess ROS, preventing OS. Moreover, OS triggers AO defenses, which ultimately yield to AD progression. Yet, to date, clinical trials involving AO supplementation have paradoxically failed, exposing large knowledge gaps in understanding which AO species are depleted, the time course of AO depletion, and the underlying mechanisms. The AO all-trans retinoic acid (ATRA), a bioactive form of Vitamin A (VA), serves a dual role as a ROS scavenger and hormone-like ligand for the retinoic acid receptor (RAR). Ligand binding to RARs is critical for transcriptional regulation of genes containing retinoic acid response elements (RAREs). Recent evidence from rodents has demonstrated an age-dependent homeostatic collapse in hippocampal ATRA levels. Moreover, there is increasing evidence that transcriptional silencing occurs in AD. To investigate ATRA depletion, we performed a secondary analysis of hippocampal transcriptomic data from post-mortem AD brains. ATRA-sensitive genes were downregulated, accompanied by upregulation of RAR repressors. Moreover, several histone deacetylases (HDACs) were upregulated, providing evidence for epigenetic changes. Given this strong scientific premise, we hypothesize that both ATRA bioavailability and HDAC inhibition are required to restore ATRA-mediated gene transcription and hippocampal-dependent learning. Therefore, our central hypothesis is that combining vitamin A supplementation and HDAC inhibition (HDACI) maintains hippocampal-dependent learning and RAR-sensitive gene transcription in DG more effectively than HDACi alone. Using an innovative multidisciplinary approach, we will determine effects of combining VA supplementation with HDAC inhibition on learning and transcription of RAR-sensitive genes in DG cell types. SA1 tests the hypothesis that VA supplementation alleviates AD-related learning deficits and multi- omic signatures in the DG. SA2 tests the hypothesis that HDAC inhibition alleviates AD-related learning deficits and multi-omic signatures in the DG. SA3 tests the hypothesis that combining VA supplementation and HDAC inhibition (VA+HDACI) synergistically alleviates AD-related learning deficits and multi-omic signatures in the DG beyond VA and HDACI alone. Successful completion of this project will increase knowledge of aberrant transcriptional mechanisms occurring in the DG during AD. Integrating behavioral and multi-omic data, the project will elucidate multi-omic signatures in DG that protect against AD, enable the discovery of new genes necessary for DG function, and determine the value of drug repurposing for an FDA- approved HDAC inhibitor.
项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John Joshua Lawrence其他文献

John Joshua Lawrence的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John Joshua Lawrence', 18)}}的其他基金

Transcriptional Dysfunction in Dentate Gyrus Cell Types: Roles of Retinoic Acid Responsive Genes in Protection Against Alzheimer's Disease Pathogenesis
齿状回细胞类型的转录功能障碍:视黄酸反应基因在预防阿尔茨海默病发病机制中的作用
  • 批准号:
    10367173
  • 财政年份:
    2022
  • 资助金额:
    $ 62.36万
  • 项目类别:
Transcriptional Dysfunction in Dentate Gyrus Cell Types: Roles of Retinoic Acid Responsive Genes in Protection Against Alzheimer's Disease Pathogenesis
齿状回细胞类型的转录功能障碍:视黄酸反应基因在预防阿尔茨海默病发病机制中的作用
  • 批准号:
    10543800
  • 财政年份:
    2022
  • 资助金额:
    $ 62.36万
  • 项目类别:
The hippocampal dentate gyrus in aging and Alzheimer's disease: boosting transcription of retinoic acid-sensitive genes through vitamin A supplementation and HDAC inhibition
衰老和阿尔茨海默病中的海马齿状回:通过补充维生素 A 和抑制 HDAC 来促进视黄酸敏感基因的转录
  • 批准号:
    10446664
  • 财政年份:
    2022
  • 资助金额:
    $ 62.36万
  • 项目类别:
Differential modes of cholinergic transmission onto cellular hippocampal targets
胆碱能传输到细胞海马靶标的不同模式
  • 批准号:
    9144946
  • 财政年份:
    2015
  • 资助金额:
    $ 62.36万
  • 项目类别:
Differential modes of cholinergic transmission onto cellular hippocampal targets
胆碱能传输到细胞海马靶标的不同模式
  • 批准号:
    8272674
  • 财政年份:
    2010
  • 资助金额:
    $ 62.36万
  • 项目类别:
Differential modes of cholinergic transmission onto cellular hippocampal targets
胆碱能传输到细胞海马靶标的不同模式
  • 批准号:
    8617333
  • 财政年份:
    2010
  • 资助金额:
    $ 62.36万
  • 项目类别:
Differential modes of cholinergic transmission onto cellular hippocampal targets
胆碱能传输到细胞海马靶标的不同模式
  • 批准号:
    8042776
  • 财政年份:
    2010
  • 资助金额:
    $ 62.36万
  • 项目类别:
Differential modes of cholinergic transmission onto cellular hippocampal targets
胆碱能传输到细胞海马靶标的不同模式
  • 批准号:
    8810769
  • 财政年份:
    2010
  • 资助金额:
    $ 62.36万
  • 项目类别:
Differential modes of cholinergic transmission onto cellular hippocampal targets
胆碱能传输到细胞海马靶标的不同模式
  • 批准号:
    8662325
  • 财政年份:
    2010
  • 资助金额:
    $ 62.36万
  • 项目类别:
Differential modes of cholinergic transmission onto cellular hippocampal targets
胆碱能传输到细胞海马靶标的不同模式
  • 批准号:
    8134323
  • 财政年份:
    2010
  • 资助金额:
    $ 62.36万
  • 项目类别:

相似海外基金

THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
  • 批准号:
    7606738
  • 财政年份:
    2007
  • 资助金额:
    $ 62.36万
  • 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
  • 批准号:
    7717960
  • 财政年份:
    2007
  • 资助金额:
    $ 62.36万
  • 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
  • 批准号:
    7205360
  • 财政年份:
    2004
  • 资助金额:
    $ 62.36万
  • 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
  • 批准号:
    6305687
  • 财政年份:
    1999
  • 资助金额:
    $ 62.36万
  • 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
  • 批准号:
    6115572
  • 财政年份:
    1998
  • 资助金额:
    $ 62.36万
  • 项目类别:
A study on the biological features of age-associated memory impairment (AAMI).
年龄相关记忆障碍(AAMI)生物学特征的研究。
  • 批准号:
    09671003
  • 财政年份:
    1997
  • 资助金额:
    $ 62.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C).
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
  • 批准号:
    6276806
  • 财政年份:
    1997
  • 资助金额:
    $ 62.36万
  • 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
  • 批准号:
    3386469
  • 财政年份:
    1990
  • 资助金额:
    $ 62.36万
  • 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
  • 批准号:
    3386468
  • 财政年份:
    1990
  • 资助金额:
    $ 62.36万
  • 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
  • 批准号:
    2247160
  • 财政年份:
    1990
  • 资助金额:
    $ 62.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了